Blog

Revolutionizing IBD Research with Innovative In Vitro Models
Catch a glimpse into the future of inflammatory bowel disease (IBD) research with our ground breaking in vitro models.
11 August 2025

Explore the crucial role of early genetic variant detection in iPSC cultures for ensuring safe, effective, and regulatory-compliant cell therapies. Learn about risk profiling and REPROCELL’s solutions.
01 August 2025

Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation
Explore how subcutaneous artery assays enhance understanding of blood pressure regulation and aid in the development of safer, more effective cardiovascular drugs.
07 July 2025

Able Biott Single-use Bioreactors Enhance the Development of Disease Models and Cell Therapy
Discover how Able Biott single-use bioreactors enhance disease modeling and cell therapy development through scalable, efficient iPSC culture solutions.
03 July 2025
Upcoming Events
Conferences we will be attending, and webinars hosted by us
Come meet us on 4 September 2025 / Maryland, USA. Venue: Bethesda North Marriott Hotel & Conference Center
Come meet us on 6-8 October (in person) & 9-10 October (virtual) at Phoenix, AZ, USA. Venue: Arizona Biltmore
Come meet us 20-21 October 2025 / ACC Liverpool Exhibition Centre, UK / Booth #B07
Corporate News
REPROCELL and Durham University Researchers Develop iPSC-Derived Full-Thickness Human Skin Model
REPROCELL and Durham University develop a reliable, iPSC-derived full-thickness human skin model for research and therapeutic applications, enhancing drug discovery and regenerative medicine.
13 August 2025
REPROCELL Announces U.S. FDA Drug Master File Submittal for StemRNA™ Clinical iPSC Seed Clones
REPROCELL is pleased to announce the successful submittal of its StemRNA™ Clinical iPSC Seed Clones with the U.S. Food and Drug Administration (FDA) via a Type II Drug Master File (DMF).
22 July 2025
Scottish Health Minister Visits REPROCELL Japan to Strengthen Life Sciences Collaboration
Scottish Health Minister Neil Gray visits REPROCELL Japan to enhance life sciences collaboration, highlighting strong ties and innovative healthcare advancements between Scotland and Japan.
02 July 2025